|
Market Closed -
Other stock markets
|
After hours 21:13:25 | |||
| 0.7100 EUR | -4.57% |
|
0.7120 | +0.28% |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 07-16 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.57% | -4.95% | +65.12% | +345.98% | +414.49% | +995.68% | +206.03% | +18.93% | -77.60% | 428M | |
| -0.69% | -8.65% | -7.08% | +15.20% | +3.76% | +45.00% | +148.08% | +324.84% | +1,252.92% | 1T | |
| -0.25% | -4.74% | -2.02% | +13.33% | +22.77% | +48.55% | +50.31% | +46.56% | +105.13% | 613B | |
| -0.66% | -7.27% | -4.20% | +17.25% | +6.82% | +23.77% | +65.21% | +112.09% | +269.24% | 433B | |
| +0.48% | -2.77% | +7.81% | +13.02% | +8.99% | +40.27% | +34.96% | +1.05% | +45.58% | 350B | |
| +0.08% | -4.45% | -0.40% | +9.45% | +13.69% | +31.74% | +39.89% | +49.49% | +54.78% | 292B | |
| +2.09% | -9.27% | -16.74% | -11.93% | -14.87% | +5.42% | +7.61% | +41.96% | +127.83% | 239B | |
| +1.75% | -8.29% | -4.20% | +8.71% | -5.43% | -1.73% | -42.05% | +0.69% | +67.63% | 206B | |
| +2.18% | -1.51% | +5.66% | +19.55% | +18.29% | +28.23% | +59.15% | +69.58% | +124.23% | 204B | |
| +0.12% | -2.27% | +1.28% | -1.07% | +6.95% | +14.64% | +66.85% | +89.59% | +64.57% | 163B | |
| +1.62% | +1.07% | +7.59% | -2.97% | +2.49% | +8.46% | -27.13% | -43.53% | -27.40% | 143B | |
| +0.60% | +4.15% | +16.83% | +15.45% | +22.81% | +45.91% | +9.51% | -3.28% | -12.05% | 134B | |
| +1.82% | -2.39% | -9.61% | +11.36% | +5.58% | +1.36% | +40.59% | +139.83% | +377.34% | 119B | |
| +0.26% | -5.64% | -3.45% | +3.10% | +4.93% | +36.90% | +42.13% | +6.84% | -9.85% | 103B | |
| -0.15% | -6.29% | -0.16% | -4.40% | -10.07% | -9.28% | -20.79% | -11.96% | +2.25% | 103B | |
| -0.10% | -2.45% | -12.59% | -18.98% | -18.96% | -8.99% | +60.89% | +66.83% | +440.16% | 70.18B | |
| -2.26% | -8.37% | -1.36% | +0.90% | +9.33% | +25.35% | +21.16% | +44.74% | +11.94% | 55.08B | |
| +2.40% | +2.59% | -5.72% | +29.01% | +30.37% | +75.49% | -6.53% | -3.16% | -48.64% | 53.26B | |
| +0.79% | -0.34% | -1.89% | -0.85% | -10.32% | -12.87% | +26.38% | -6.93% | +228.63% | 51.77B | |
| -1.27% | -6.09% | -0.22% | +7.10% | -4.56% | +0.53% | +11.17% | - | - | 42.85B | |
| Average | +0.27% | -2.66% | +1.73% | +23.46% | +25.35% | +69.72% | +39.67% | +49.69% | +157.72% | 218.77B | |
| Weighted average by Cap. | +0.25% | -3.63% | -2.41% | +10.16% | +7.27% | +30.27% | +59.11% | +108.92% | +375.27% |
- Stock Market
- Stocks
- ALVIO Stock
- Sector Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
